Anixa Biosciences, Inc.
General ticker "ANIX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $109.0M (TTM average)
Anixa Biosciences, Inc. does not follow the US Stock Market performance with the rate: -1.7%.
Estimated limits based on current volatility of 2.9%: low 2.64$, high 2.80$
Factors to consider:
- Total employees count: 4 (-20.0%) as of 2025
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: History of losses, Need additional capital, Operational and conduct risks, Clinical trial failure, Regulatory and compliance
- Current price 11.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-10-31 to 2027-10-31
- 2025-10-31 to 2026-10-31 estimated range: [3.02$, 6.39$]
- 2026-10-31 to 2027-10-31 estimated range: [2.87$, 6.10$]
Financial Metrics affecting the ANIX estimates:
- Positive: with PPE of -11.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 94.28 > 81.92
- Positive: Investing cash flow per share per price, % of 3.60 > 2.08
Short-term ANIX quotes
Long-term ANIX plot with estimates
Financial data
| YTD | 2023-10-31 | 2024-10-31 | 2025-10-31 |
|---|---|---|---|
| Operating Revenue | $0.21MM | $0.00MM | $0.00MM |
| Operating Expenses | $11.22MM | $13.83MM | $11.70MM |
| Operating Income | $-11.01MM | $-13.83MM | $-11.70MM |
| Non-Operating Income | $1.08MM | $1.13MM | $0.67MM |
| R&D Expense | $4.77MM | $6.40MM | $5.07MM |
| Income(Loss) | $-9.93MM | $-12.70MM | $-11.03MM |
| Net Income(Loss)* | $-9.81MM | $-12.55MM | $-10.93MM |
| Stockholders Equity | $24.34MM | $20.00MM | $15.16MM |
| Assets | $25.52MM | $21.59MM | $16.08MM |
| Operating Cash Flow | $-6.21MM | $-7.33MM | $-7.17MM |
| Investing Cash Flow | $-5.60MM | $4.28MM | $4.87MM |
| Financing Cash Flow | $0.37MM | $3.42MM | $2.28MM |
| Earnings Per Share** | $-0.32 | $-0.39 | $-0.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.